The nationwide lockdown in India in 2020 due to the COVID-19 pandemic had a negative impact on women’s nutrition in the country, according to a study conducted by a group of researchers in the US.
The study by Tata-Cornell Institute for Agriculture and Nutrition in four economically backward districts of Uttar Pradesh’s Maharajganj, Bihar’s Munger, and Odisha’s Kandhamal and Kalahandi indicate a decline in household food expenditures and women’s dietary diversity in May 2020 compared to May 2019, particularly for non-staples like meats, eggs, vegetables and fruits.
It occurred despite the special Public Distribution System (PDS), direct benefit transfer and ration from aanganwadis reaching 80 per cent, 50 per cent and 30 per cent of the surveyed households, respectively, said the study published in the latest issue of Economia Politica journal.
“Our findings contribute to the growing body of evidence of women's disproportionate vulnerability to economic shocks, the impact of a staple grain focused safety net programme, and restricted markets on the access and availability of diverse nutritious foods,” says the paper which makes a case for policy reforms towards PDS diversification to include nutrition-rich foods and market reforms to remove supply-side bottlenecks and expansion of direct benefit transfers for healthy food access.
“Women’s diets were lacking in diverse foods even before the pandemic, but COVID-19 has further exacerbated the situation,” said Soumya Gupta, a research economist at TCI who co-authored the study along with Prabhu Pingali, TCI director; Mathew Abraham, assistant director; and consultant Payal Seth.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
“Any policies addressing the impact of the pandemic on nutritional outcomes must do so through a gendered lens that reflects the specific, and often persistent, vulnerabilities faced by women,” she said in a statement issued by the Cornell University.Researchers said that policymakers should recognise the disproportionate impact of the pandemic and other disruptive events on women’s nutrition by bolstering safety-net programmes to ensure that they meet the needs of women and other marginalised groups.